How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?

The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed to lower levels of health care spending; however, their impact has been limited and not sustained over time. Costly new technology, while often an improvement to existing care, has been identified as a principal driver of health care spending growth. Recent literature has shown that high deductible health plans (HDHP) can have an immediate impact on levels of health care spending, but their medium- and long-run effects on spending growth remain unknown.

In this paper, investigators use multiple-employer-group claims data from a large national insurer to (i) study whether HDHPs reduce the growth in spending over four years compared to lower deductible alternatives; and (ii) explore the mechanisms behind any reductions in growth by looking at whether HDHPs reduce the use of low- vs. high-value treatments. They found that HDHPs have a limited effect on spending growth, with a statistically significant reduction observed only for prescription drugs. HDHPs are not associated with significantly lower growth in spending on highly cost-effective medicines in a sample of drugs but do reduce spending growth for less cost-effective drugs. Access the full study here.

(Source: Lucarelli, Claudio, Frean, Molly, Gordon, Aliza S., Hua, Lynn M. and Pauly, Mark, (2020), How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments? Evidence from Deductibles, No 28155, NBER Working Papers, National Bureau of Economic Research, Inc)